Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fresenius Medical Care : Healthcare group Fresenius raises 2021 forecasts

07/30/2021 | 11:06am EDT
FILE PHOTO: Samples of products of Fresenius and Fresenius Medical Care are on display during the company's annual news conference at their head quarters in Bad Homburg

(Reuters) - German healthcare group Fresenius raised 2021 targets though it saw a weaker third quarter, saying progress on its cost-cutting plan should offset troubles at its dialysis unit.

The COVID-19 pandemic has affected healthcare groups in different ways as demand for coronavirus-related products and services coincided with the evolution of new coronavirus variants and higher rates of patient deaths.

Fresenius said that while it earlier expected lower pandemic effects in late 2021, new coronavirus variants and exposure to high-risk patients at its dialysis unit Fresenius Medical Care could threaten those assumptions in the third quarter.

"We obviously need to watch the further development and the related knock-on effects of the pandemic here very closely," Fresenius' chief executive Stephan Sturm said in a conference call on Friday.

However, higher 2021 numbers are still possible thanks to better-than-expected savings from Fresenius' cost-cutting plan, Sturm said.

"For starters, we expect low double-digit million euro savings already this year," the CEO said.

At the same time, the company still did not specify savings measures for FMC, saying it would issue an update in autumn.

Earlier this year, Fresenius sparked speculation it might divest the unit, but Sturm dismissed that possibility on May 21.

"FMC gets us more scale, a higher level of attractiveness in the debt markets and advantages on the tax front," Sturm said on Friday, adding Fresenius is still analyzing its group structure and may give a further update in February.

In a statement released earlier on Friday, Fresenius said it now saw 2021 net income growing in a low single-digit percentage range and kept expected revenue growth at a low to medium single-digit percentage range, both in constant currency. In May, it said it expected at least broadly stable net income.

($1 = 0.8418 euros)

(Reporting by Zuzanna Szymanska and Karol Badohal in Gdansk; Editing by Tomasz Janowski)

By Zuzanna Szymanska and Karl Badohal


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA 0.10% 61.32 Delayed Quote.-10.09%
FRESENIUS SE & CO. KGAA -0.47% 41.12 Delayed Quote.8.67%
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
09/23European ADRs Move Sharply Higher in Thursday Trading
MT
09/23FRESENIUS MEDICAL CARE PUBLISHES 202 : Embracing the Complexity of Global Healthcare
PU
09/23FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 40, Section 1 of the W..
DJ
09/23FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 40, Section 1 of the W..
EQ
09/22FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from Berenberg
MD
09/22FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs gives a Buy rating
MD
09/20FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Sell rating from Jefferies
MD
09/20PRESS RELEASE : Rentschler Biopharma appoints Dr. Christian Schetter as Chief Scientific O..
DJ
09/17FRESENIUS MEDICAL CARE : Selects JMS Co. as Distributor of Home Dialysis Systems in Japan
MT
09/17FMC FRESENIUS MEDICAL CARE AG & CO K : Sell rating from Jefferies
MD
More news
Analyst Recommendations on FRESENIUS MEDICAL CARE AG & CO. KGAA
More recommendations
Financials (USD)
Sales 2021 21 180 M - -
Net income 2021 1 274 M - -
Net Debt 2021 13 395 M - -
P/E ratio 2021 16,3x
Yield 2021 1,95%
Capitalization 21 052 M 21 037 M -
EV / Sales 2021 1,63x
EV / Sales 2022 1,53x
Nbr of Employees 123 538
Free-Float 67,8%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Last Close Price 71,85 $
Average target price 80,61 $
Spread / Average Target 12,2%
EPS Revisions
Managers and Directors
Rice Powell Chief Executive Officer
Helen Giza Chief Financial Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer